CBRE vs SLNO · P/E 43, rev $21.75B vs P/E 27, $2.76B cap
CBRE Group Inc Class A (CBRE) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
SLNO does not have a complete income-statement cache yet.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the CBRE and SLNO stock pages for the full models.
Not investment advice.